OR WAIT null SECS
Click here to read the articles and download the PDF
While generics and adherence challenges are keeping drugmakers up at night, breakthroughs in the pipeline coupled with innovative uses of artificial intelligence and machine learning techniques are bringing optimism to the cardiovascular disease space.
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.
The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.
June 09, 2023
Agreement provides Vizient clients—including hospital systems and healthcare suppliers—with additional access to logistics solutions, such as warehousing and distribution.
Biopharmas are able to industry insight to assist them across the end-to-end product lifecycle.
June 08, 2023
Sy Pretorius, COO & president of outsourced solutions at Eversana, dives into his new role in the space, after being a veteran in the clinical development sector.
Pharma company claims that the IRA’s drug pricing clauses violate the First and Fifth Amendments.
Partnership intends to reduce treatment costs, while also increasing medication access.
June 07, 2023
Software company’s branded orchestration platform helps to track chain of identity and chain of custody.
New space will assist pharma companies with cold chain solutions, including commercial product distribution.
June 06, 2023
However, April numbers show that capacity is up 13.4% compared to April of last year.
Indicates that reimbursement for new slate of Alzheimer’s treatments will occur only with the completion of studies to support full approval.
June 05, 2023
Decision is anticipated to boost operational efficiencies for the CDMO.